At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
Phonak Audeo hearing aiddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hearing Aid Quality Check and Reliability Study
In Brief
A clinical study evaluating Phonak Audeo hearing aid for Hearing Loss. Completed, enrolled 19 participants across 1 site.
Detailed Summary
Quality and reliability study of hearing aid. Adults with mild to severe hearing loss will wear hearing aids daily for approximately 3 months.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJun 2021
First PostedAug 2021
Primary CompletionSep 2021
Study CompletionOct 2021
TodayJul 2026
First PostedAug 9, 2021
Enrollment StartJun 8, 2021
Primary CompletionSep 13, 2021
Study CompletionOct 31, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 4.9 years ago
Interventions
Phonak Audeo hearing aiddevice
Rechargeable hearing aid